ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling

A Disintegrin and Metalloproteinases (ADAMs) are the principal enzymes for shedding receptor tyrosine kinase (RTK) ectodomains and ligands from the cell surface. Multiple layers of activity regulation, feedback, and catalytic promiscuity impede our understanding of context-dependent ADAM “sheddase”...

Full description

Bibliographic Details
Main Authors: Miller, Miles Aaron, Meyer, Aaron Samuel, Beste, Michael T., Lasisi, Zainab A., Reddy, Sonika N., Jeng, Karen, Griffith, Linda G., Lauffenburger, Douglas A., Chen, Chia-Hung, Han, Jongyoon, Isaacson, Keith B.
Other Authors: Massachusetts Institute of Technology. Center for Gynepathology Research
Format: Article
Language:en_US
Published: National Academy of Sciences (U.S.) 2013
Online Access:http://hdl.handle.net/1721.1/83378
https://orcid.org/0000-0002-1801-5548
_version_ 1826201436879323136
author Miller, Miles Aaron
Meyer, Aaron Samuel
Beste, Michael T.
Lasisi, Zainab A.
Reddy, Sonika N.
Jeng, Karen
Griffith, Linda G.
Lauffenburger, Douglas A.
Chen, Chia-Hung
Han, Jongyoon
Isaacson, Keith B.
author2 Massachusetts Institute of Technology. Center for Gynepathology Research
author_facet Massachusetts Institute of Technology. Center for Gynepathology Research
Miller, Miles Aaron
Meyer, Aaron Samuel
Beste, Michael T.
Lasisi, Zainab A.
Reddy, Sonika N.
Jeng, Karen
Griffith, Linda G.
Lauffenburger, Douglas A.
Chen, Chia-Hung
Han, Jongyoon
Isaacson, Keith B.
author_sort Miller, Miles Aaron
collection MIT
description A Disintegrin and Metalloproteinases (ADAMs) are the principal enzymes for shedding receptor tyrosine kinase (RTK) ectodomains and ligands from the cell surface. Multiple layers of activity regulation, feedback, and catalytic promiscuity impede our understanding of context-dependent ADAM “sheddase” function and our ability to predictably target that function in disease. This study uses combined measurement and computational modeling to examine how various growth factor environments influence sheddase activity and cell migration in the invasive disease of endometriosis. We find that ADAM-10 and -17 dynamically integrate numerous signaling pathways to direct cell motility. Data-driven modeling reveals that induced cell migration is a quantitative function of positive feedback through EGF ligand release and negative feedback through RTK shedding. Although sheddase inhibition prevents autocrine ligand shedding and resultant EGF receptor transactivation, it also leads to an accumulation of phosphorylated receptors (HER2, HER4, and MET) on the cell surface, which subsequently enhances Jnk/p38 signaling. Jnk/p38 inhibition reduces cell migration by blocking sheddase activity while additionally preventing the compensatory signaling from accumulated RTKs. In contrast, Mek inhibition reduces ADAM-10 and -17 activities but fails to inhibit compensatory signaling from accumulated RTKs, which actually enhances cell motility in some contexts. Thus, here we present a sheddase-based mechanism of rapidly acquired resistance to Mek inhibition through reduced RTK shedding that can be overcome with rationally directed combination inhibitor treatment. We investigate the clinical relevance of these findings using targeted proteomics of peritoneal fluid from endometriosis patients and find growth-factor–driven ADAM-10 activity and MET shedding are jointly dysregulated with disease.
first_indexed 2024-09-23T11:51:33Z
format Article
id mit-1721.1/83378
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:51:33Z
publishDate 2013
publisher National Academy of Sciences (U.S.)
record_format dspace
spelling mit-1721.1/833782022-09-27T22:24:45Z ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling Miller, Miles Aaron Meyer, Aaron Samuel Beste, Michael T. Lasisi, Zainab A. Reddy, Sonika N. Jeng, Karen Griffith, Linda G. Lauffenburger, Douglas A. Chen, Chia-Hung Han, Jongyoon Isaacson, Keith B. Massachusetts Institute of Technology. Center for Gynepathology Research Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Chemical Engineering Miller, Miles Aaron Meyer, Aaron Samuel Beste, Michael T. Lasisi, Zainab A. Reddy, Sonika N. Jeng, Karen Griffith, Linda G. Lauffenburger, Douglas A. A Disintegrin and Metalloproteinases (ADAMs) are the principal enzymes for shedding receptor tyrosine kinase (RTK) ectodomains and ligands from the cell surface. Multiple layers of activity regulation, feedback, and catalytic promiscuity impede our understanding of context-dependent ADAM “sheddase” function and our ability to predictably target that function in disease. This study uses combined measurement and computational modeling to examine how various growth factor environments influence sheddase activity and cell migration in the invasive disease of endometriosis. We find that ADAM-10 and -17 dynamically integrate numerous signaling pathways to direct cell motility. Data-driven modeling reveals that induced cell migration is a quantitative function of positive feedback through EGF ligand release and negative feedback through RTK shedding. Although sheddase inhibition prevents autocrine ligand shedding and resultant EGF receptor transactivation, it also leads to an accumulation of phosphorylated receptors (HER2, HER4, and MET) on the cell surface, which subsequently enhances Jnk/p38 signaling. Jnk/p38 inhibition reduces cell migration by blocking sheddase activity while additionally preventing the compensatory signaling from accumulated RTKs. In contrast, Mek inhibition reduces ADAM-10 and -17 activities but fails to inhibit compensatory signaling from accumulated RTKs, which actually enhances cell motility in some contexts. Thus, here we present a sheddase-based mechanism of rapidly acquired resistance to Mek inhibition through reduced RTK shedding that can be overcome with rationally directed combination inhibitor treatment. We investigate the clinical relevance of these findings using targeted proteomics of peritoneal fluid from endometriosis patients and find growth-factor–driven ADAM-10 activity and MET shedding are jointly dysregulated with disease. National Institutes of Health (U.S.) (Grant R01-EB10246) National Institutes of Health (U.S.) (Grant U54-CA112967) David H. Koch Institute for Integrative Cancer Research at MIT (Frontier Research Program Initiator Award) Repligen Corporation (Fellowship in Cancer Research) 2013-12-30T18:34:02Z 2013-12-30T18:34:02Z 2013-05 2012-12 Article http://purl.org/eprint/type/JournalArticle 0027-8424 1091-6490 http://hdl.handle.net/1721.1/83378 Miller, M. A., A. S. Meyer, M. T. Beste, Z. Lasisi, S. Reddy, K. W. Jeng, C.-H. Chen, et al. “ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling.” Proceedings of the National Academy of Sciences 110, no. 22 (May 28, 2013): E2074-E2083. https://orcid.org/0000-0002-1801-5548 en_US http://dx.doi.org/10.1073/pnas.1222387110 Proceedings of the National Academy of Sciences Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf National Academy of Sciences (U.S.) PNAS
spellingShingle Miller, Miles Aaron
Meyer, Aaron Samuel
Beste, Michael T.
Lasisi, Zainab A.
Reddy, Sonika N.
Jeng, Karen
Griffith, Linda G.
Lauffenburger, Douglas A.
Chen, Chia-Hung
Han, Jongyoon
Isaacson, Keith B.
ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title_full ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title_fullStr ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title_full_unstemmed ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title_short ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
title_sort adam 10 and 17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
url http://hdl.handle.net/1721.1/83378
https://orcid.org/0000-0002-1801-5548
work_keys_str_mv AT millermilesaaron adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT meyeraaronsamuel adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT bestemichaelt adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT lasisizainaba adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT reddysonikan adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT jengkaren adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT griffithlindag adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT lauffenburgerdouglasa adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT chenchiahung adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT hanjongyoon adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling
AT isaacsonkeithb adam10and17regulateendometrioticcellmigrationviaconcertedligandandreceptorsheddingfeedbackonkinasesignaling